LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Medtronic Coats Titanium to PEEK for New Spine Implants
Spine

Medtronic Coats Titanium to PEEK for New Spine Implants

October 22, 2014 2 min read Premium comments

Advertisement

Medtronic Coats Titanium to PEEK for New Spine Implants
Titanium Coated Peek Interbody Fusion Devices / Courtesy: Medtronic, Inc.
Secondary

Over the past ten years, PEEK (polyetheretherketone) has largely replaced titanium as the material of choice for orthopedic implants.

But now, Medtronic, Inc. is marrying the two materials together, calling it an “evolution in interbody fusion technology” by constructing devices made with a combination of the two materials in a “Pure Titanium Coating” (PTC) platform. The company applies a thin layer of textured pure titanium about 1/10th of a millimeter thick to the top and bottom of each four different PEEK implants. The implants include two spinal systems, a PEEK cervical fusion system and a cervical cage.

The company introduced the new platform on October 20, 2014 at the Congress of Neurological Surgeons (CNS) Annual Meeting in Boston.

“Surgeons, ” according to the company, “have historically preferred interbody spacers made of titanium because of their strength and long clinical history.” But PEEK “replaced titanium because it has a modulus of elasticity that is similar to human cortical bone and it does not show up on X-rays. This radiolucency lets the surgeon assess the surgical site more easily after surgery.”

The company says that mechanical testing has shown that compared to PEEK alone, the pure titanium coating has a greater coefficient of friction. “Additionally, this textured coating increases the surface area of the implant, which means there is more area for bone to come into contact with the surface of the implant. Yet, the titanium layer is thin enough that it does not change the radiolucency or mechanical properties of the underlying PEEK implant, ” said the company statement.

The four products in the company’s new PTC platform include:

FDA 510(k) clearance for the Capstone and Clydesdale spinal systems was received in March and the products were launched in the U.S. in August. Both systems received CE Mark (Conformité Européenne) in July. The Capstone was launched in Western Europe in September and is expected to be launched in Japan in November 2015. The Clydesdale launch in Japan is projected to be in January 2016.

FDA 510(k) clearance was received for the Anatomic PEEK PTC cervical fusion system, which was launched in the U.S. in September.

Advertisement

CE Mark for the Cornerstone-SR Ti-Coated anatomical cervical cage has been received and the product—not for use in the U.S. or its territories—launched in Western Europe in July.

Doug King, president of Medtronic’s spine business and senior VP at Medtronic, said, “Our PTC platform of interbody spacers is the result of our relentless effort to add value to our products and respond to surgeon needs by offering the advantages of combined materials in a single implant. We will continue to leverage our innovation to produce more advanced and differentiated products for surgeons to use to treat their patients.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy